Inventiva SA
PAR:IVA

Watchlist Manager
Inventiva SA Logo
Inventiva SA
PAR:IVA
Watchlist
Price: 3.45 EUR -2.13% Market Closed
Market Cap: 659m EUR

Wall Street
Price Targets

IVA Price Targets Summary
Inventiva SA

Wall Street analysts forecast IVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IVA is 12.18 EUR with a low forecast of 3.03 EUR and a high forecast of 23.45 EUR.

Lowest
Price Target
3.03 EUR
12% Downside
Average
Price Target
12.18 EUR
253% Upside
Highest
Price Target
23.45 EUR
580% Upside
Inventiva SA Competitors:
Price Targets
688331
RemeGen Co Ltd
8% Upside
RNA
Avidity Biosciences Inc
3% Upside
302440
SK Bioscience Co Ltd
26% Downside
ALT
Altimmune Inc
261% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
36% Upside
MRNA
Moderna Inc
37% Upside
INSM
Insmed Inc
9% Upside
688382
InventisBio Co Ltd
73% Upside

Revenue
Forecast

Revenue Estimate
Inventiva SA

For the last 10 years the compound annual growth rate for Inventiva SA's revenue is 11%. The projected CAGR for the next 3 years is 48%.

11%
Past Growth
48%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Inventiva SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Inventiva SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IVA's stock price target?
Price Target
12.18 EUR

According to Wall Street analysts, the average 1-year price target for IVA is 12.18 EUR with a low forecast of 3.03 EUR and a high forecast of 23.45 EUR.

What is Inventiva SA's Revenue forecast?
Projected CAGR
48%

For the last 10 years the compound annual growth rate for Inventiva SA's revenue is 11%. The projected CAGR for the next 3 years is 48%.

Back to Top